Please note: AABB reserves the right to make updates to this program.
Live Program Date: Wednesday, May 16, 2018 -
Master Program Number: 18EL-333 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Physicians, Scientists, Technologists, Nurses, Managers/Supervisors, CEOs, CFOs, Laboratory Staff, Medical Directors, Students/Fellows, Residents, Hospital Blood Banks
Teaching Level: Intermediate
Director/Moderator: Suchitra Pandey, MD, Senior Chief Medical Officer, Blood Systems, Inc (Blood Centers of the Pacific), San Francisco, CA
Speakers: Samantha E. Mack, MD, Medical Director, Bonfils Blood Center, United Blood Services, Denver, CO; Justin D. Kreuter, MD, Consultant, Transfusion Medicine, Medical Director, Blood Donor Program, Associate Medical Director, Histocompatibility Laboratory, Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN; Patricia Kopko, M.D., Director, Transfusion Medicine, Associate Director, Immunogenetics and Transplantation Laboratory, University of California, San Diego, CA
After participating in this educational activity, participants should be able to:
- Review experience of implementing pathogen reduced platelets at a Blood Center including optimizing collection platform settings and increasing the availability of platelets to pathogen reduce by splitting larger collections to meet set guard bands.
- Discuss gauging hospital interest and demand for pathogen reduction in the current environment including a review of cost related issues.
- Identify at least two lessons learned by the hospital transfusion service when implementing pathogen reduced products
- Describe the development of a policy regarding providing pathogen reduced platelets to patients in the setting of a dual inventory.
Pathogen reduction is being implemented throughout the US to mitigate transfusion-transmitted infectious risks. Multiple US blood centers are either already distributing or are preparing to distribute pathogen reduced platelets to hospitals. In this program, the speakers will review their experiences in implementing pathogen reduction at their Blood Center and/or Hospital Transfusion Service. They will discuss challenges faced and lessons learned by their respective institution’s including methods to optimize production at the Blood Center and managing a dual inventory in the Transfusion Service.
While presented with a different perspective, participants may also be interested in eCast 18EL-350 entitled, “HOT TOPIC: Challenges and Solutions to Implementation of Licensed PI for Platelets”.
| || ||
|Single Viewer: On-Demand||
|Group Viewing: On-Demand||
Continuing Education Credit
AABB designates both the live and on-demand version of this eCast each eligible for 1.5 continuing education credit/contact hour for Physicians, General Participation, California Nurse, California Lab Personnel and Florida Lab Personnel. The number and type of credits awarded for this program (both live and on-demand) was determined by the program duration. For more information on each credit type please visit our Continuing Education Credits webpage.
Disclosures for the planners of this event can be found here. Disclosures for the program faculty are provided at the beginning of the program.
Dr. Kopko is a professor of pathology at the University of California, San Diego where she serves as the Director of Transfusion Medicine, the Associate Director of the Immunogenetics and Transplantation Laboratory and the Associate Director of the Pathology Residency Training Program.